UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: The OPUS study

Bone (New York, N.Y.), 2013-11, Vol.57 (1), p.232-236

2013

Volltextzugriff (PDF)

FRAX®: prediction of major osteoporotic fractures in women from the general population: the OPUS study

PloS one, 2013-12, Vol.8 (12), p.e83436-e83436

2013

Volltextzugriff (PDF)

Bone mineral density and bone remodeling markers in chronic low back pain patients with active discopathy: A case-control exploratory study

PloS one, 2018-06, Vol.13 (6), p.e0196536-e0196536

2018

Volltextzugriff (PDF)

Oxytocin, a New Determinant of Bone Mineral Density in Post-Menopausal Women: Analysis of the OPUS Cohort

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.E634-E641

2014

Volltextzugriff (PDF)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

Rheumatic & musculoskeletal diseases open, 2023-02, Vol.9 (1), p.e002676

2023

Volltextzugriff (PDF)

Frequency and causes of high bone mass

Bone Reports, 2020-10, Vol.13, p.100613, Article 100613

2020

Volltextzugriff (PDF)

The French Multicentre Elevated Bone Mass Study: Prevalence and causes

Bone Reports, 2021-04, Vol.14, p.100852, Article 100852

2021

Volltextzugriff (PDF)

Bone Mineral Density Evolution and Its Determinants in Long‐term Survivors of Childhood Acute Leukemia

HemaSphere, 2021-02, Vol.5 (2), p.e518-n/a

2021

Volltextzugriff (PDF)

Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy

Journal of rheumatology, 2008-02, Vol.35 (2), p.310

2008

Volltextzugriff (PDF)

Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial

Current HIV research, 2011-01, Vol.9 (1), p.31-39

2011

Volltextzugriff (PDF)

Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scans

Rheumatology, 2022-08, Vol.61 (8), p.3269-3278

2022

Volltextzugriff (PDF)

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

AIDS (London), 2009-04, Vol.23 (7), p.817-824

2009

Volltextzugriff (PDF)

High bone mass in adults

Joint, bone, spine : revue du rhumatisme, 2018-12, Vol.85 (6), p.693-699

2018

Volltextzugriff (PDF)

Identification of Rheumatoid Arthritis Patients With Vertebral Fractures Using Bone Mineral Density and Trabecular Bone Score

Journal of clinical densitometry, 2012-07, Vol.15 (3), p.260-266

2012

Volltextzugriff (PDF)

The French multicentre elevated bone mass study: prevalence and causes

Osteoporosis international, 2021-09, Vol.32 (9), p.1763-1775

2021

Volltextzugriff (PDF)

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment

Journal of rheumatology, 2014-06, Vol.41 (6), p.1112-1117

2014

Volltextzugriff (PDF)

Vertebral strength prediction from Bi-Planar dual energy x-ray absorptiometry under anterior compressive force using a finite element model: An in vitro study

Journal of the mechanical behavior of biomedical materials, 2018-11, Vol.87, p.190-196

2018

Volltextzugriff (PDF)

Prevalence and causes of elevated bone mass

Bone (New York, N.Y.), 2020-09, Vol.138, p.115476-115476, Article 115476

2020

Volltextzugriff (PDF)

Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

Nature medicine, 2023-10, Vol.29 (10), p.2615-2624

2023

Volltextzugriff (PDF)

Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events

Rheumatology (Oxford, England), 2020-09, Vol.59 (9), p.2581-2590

2020

Volltextzugriff (PDF)

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis

Joint, bone, spine : revue du rhumatisme, 2012-05, Vol.79 (3), p.304-313

2012

Volltextzugriff (PDF)

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Journal of antimicrobial chemotherapy, 2019-09, Vol.74 (9), p.2742-2751

2019

Volltextzugriff (PDF)

Radiographic methods for evaluating osteoporotic vertebral fractures

Joint, bone, spine : revue du rhumatisme, 2009-05, Vol.76 (3), p.241-247

2009

Volltextzugriff (PDF)

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

AIDS (London), 2013-09, Vol.27 (15), p.2425-2430

2013

Volltextzugriff (PDF)

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response

Journal of antimicrobial chemotherapy, 2020-12, Vol.75 (12), p.3699-3700

2020

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(70)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: The OPUS study

FRAX®: prediction of major osteoporotic fractures in women from the general population: the OPUS study

Bone mineral density and bone remodeling markers in chronic low back pain patients with active discopathy: A case-control exploratory study

Oxytocin, a New Determinant of Bone Mineral Density in Post-Menopausal Women: Analysis of the OPUS Cohort

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

Frequency and causes of high bone mass

The French Multicentre Elevated Bone Mass Study: Prevalence and causes

Bone Mineral Density Evolution and Its Determinants in Long‐term Survivors of Childhood Acute Leukemia

Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy

Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial

Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scans

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

High bone mass in adults

Identification of Rheumatoid Arthritis Patients With Vertebral Fractures Using Bone Mineral Density and Trabecular Bone Score

The French multicentre elevated bone mass study: prevalence and causes

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment

Vertebral strength prediction from Bi-Planar dual energy x-ray absorptiometry under anterior compressive force using a finite element model: An in vitro study

Prevalence and causes of elevated bone mass

Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Radiographic methods for evaluating osteoporotic vertebral fractures

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response

Suchergebnisse filtern